<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03376373</url>
  </required_header>
  <id_info>
    <org_study_id>MH100268</org_study_id>
    <nct_id>NCT03376373</nct_id>
  </id_info>
  <brief_title>Neurotherapy to Promote Emotion Recognition in Autism</brief_title>
  <official_title>Neurotherapy to Promote Emotion Recognition in Autism</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Virginia Polytechnic Institute and State University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Virginia Polytechnic Institute and State University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Autism Spectrum Disorder (ASD) is a neurodevelopmental disorder, more prevalent than&#xD;
      previously thought and heterogeneous in expression, though uniformly characterized by severe&#xD;
      social disability. The social disability that defines ASD pervades other areas of adaptive&#xD;
      behavior, is predictive of secondary mental health problems, and adversely affects long-term&#xD;
      outcome. Although ASD is a chronic condition, there has been little research on interventions&#xD;
      for adults with ASD. This study proposes to first establish the neural plasticity of specific&#xD;
      brain mechanisms underlying difficulties with facial emotion recognition, a core deficit&#xD;
      believed to be pivotal in the behavioral expression of ASD-social disability. The&#xD;
      investigators will then develop a novel, computer-based intervention using real-time&#xD;
      feedback, to the user, to ameliorate emotion recognition deficits.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Individuals with autism spectrum disorder (ASD) are known to have difficulty in the&#xD;
      recognition of facial emotion. Such deficits in facial emotion recognition (FER) are thought&#xD;
      to cause or exacerbate social disability in ASD by preventing 1) accurate detection of&#xD;
      social/emotional information conveyed through the face and, subsequently 2) the deployment of&#xD;
      emotionally appropriate responses. Consistent with this model, FER deficits are correlated&#xD;
      with social disability in ASD and confer morbidity above and beyond core symptoms.&#xD;
&#xD;
      The long-term goal is to understand how FER networks can be manipulated for therapeutic and&#xD;
      preventative purposes. In this trial, investigators are testing the feasibility of an&#xD;
      intervention that capitalizes on our previously developed brain-computer interface (BCI) to&#xD;
      promote FER in a mixed virtual reality world. The new &quot;FER Assistant&quot; tool (deployed on a&#xD;
      tablet - iPad) is intended to aid users in detecting emotions and intents of 'avatars'&#xD;
      inhabiting a virtual world, and will provide users with a highly realistic testbed for&#xD;
      practicing FER skills in concert with BCI.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 1, 2016</start_date>
  <completion_date type="Actual">December 31, 2019</completion_date>
  <primary_completion_date type="Actual">December 31, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
    <masking_description>independent evaluators are masked to condition assignment</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>facial emotion recognition (RMET)</measure>
    <time_frame>5 weeks</time_frame>
    <description>Change in facial emotion recognition 5 weeks after baseline appointment</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">28</enrollment>
  <condition>Autism Spectrum Disorder</condition>
  <arm_group>
    <arm_group_label>active</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Neurofeedback for FER</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>waiting list</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>neurofeedback</intervention_name>
    <description>real-time feedback on accuracy of emotion recognition</description>
    <arm_group_label>active</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  diagnosis of ASD&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  No severe psychopathology which warrants other immediate treatment&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>29 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Richey</last_name>
    <role>Principal Investigator</role>
    <affiliation>Virginia Polytechnic Institute and State University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Child Study Center</name>
      <address>
        <city>Blacksburg</city>
        <state>Virginia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>December 18, 2016</study_first_submitted>
  <study_first_submitted_qc>December 12, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">December 18, 2017</study_first_posted>
  <last_update_submitted>September 12, 2020</last_update_submitted>
  <last_update_submitted_qc>September 12, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 16, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Virginia Polytechnic Institute and State University</investigator_affiliation>
    <investigator_full_name>John Richey</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Autistic Disorder</mesh_term>
    <mesh_term>Autism Spectrum Disorder</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

